Patients with peripheral artery disease undergoing percutaneous peripheral interventions are at increased risk for complications without adequate anticoagulation
Allie, D.E.
Journal of Invasive Cardiology 16 Suppl G: 18-20
2004
ISSN/ISBN: 1042-3931 PMID: 23570204 Document Number: 570013
Percutaneous peripheral interventions (PPI) are often complex procedures performed on high-risk patients with a significant thrombus burden. Although there is no approved anticoagulant for use in PPI, heparin is commonly used but is associated with several limitations. The APPROVE data provide a foundation for further study of bivalirudin in the setting of PPI.
Document emailed within 1 workday
Related Documents
Liu, J.-H.; Lin, H.-H.; Yang, Y.-F.; Liu, Y.-L.; Kuo, H.-L.; Wang, I.-K.; Chou, C.-Y.; Huang, C.-C. 2009: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(1): 64-71Lobmann, R.; Kasten, G.; Kasten, U.; Lehnert, H. 2002: Association of increased plantar pressures with peripheral sensorimotor and peripheral autonomic neuropathy in Type 2 diabetic patients Diabetes Nutrition and Metabolism 15(3): 165-168
Calanca, L.; Alatri, A.; Lanzi, S.; Deglise, S.éb.; Mazzolai, L. 2019: Lower extremity peripheral artery disease : local and systemic complications Revue Medicale Suisse 15(674): 2247-2250
Anaya-Ayala, J.E.; Chen, G.J.; Davies, M.G.; Lumsden, A.B. 2012: Technological devices in peripheral percutaneous interventions Minerva Cardioangiologica 60(2): 237-255
Sim, E.K.; Koo, G.; Adebo, O.A.; Lim, M.C.; Choo, M.H.; Lee, C.N. 1993: Prevalence of peripheral artery disease in patients with coronary artery disease Annals of the Academy of Medicine Singapore 22(6): 898-900
Varma, M.K.; Puri, G.D.; Chari, P.; Verma, J.S.; Kohli, K.K. 1996: Perioperative myocardial infarction in coronary artery disease patients and 'at-risk' for coronary artery disease patients undergoing non-cardiac surgery National Medical Journal of India 9(5): 214-217
Atmer, B.; Jogestrand, T.; Laska, J.; Lund, F. 1995: Peripheral artery disease in patients with coronary artery disease International Angiology: a Journal of the International Union of Angiology 14(1): 89-93
Diehm, C.; Mörl, H.; Schettler, G. 1983: Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease Zeitschrift für Kardiologie 72(1): 44-47
McCoy, K.L.; Goldstein, D.R.; Gahtan, V.; Mayro, G.; Kerstein, M.D. 2001: Peripheral vascular disease intervention in patients with end-stage renal disease: few complications in those treated with peritoneal dialysis Southern Medical Journal 94(10): 1002-1005
Kearney, M.; Pieczek, A.; Haley, L.; Losordo, D.W.; Andres, V.; Schainfeld, R.; Rosenfield, K.; Isner, J.M. 1997: Histopathology of in-stent restenosis in patients with peripheral artery disease Circulation 95(8): 1998-2002
Chen, W.-H.; Lau, C.-P.; Lau, Y.-K.; Ng, W.; Lee, P.-Y.; Yu, C.-M.; Ma, E. 2002: Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention Journal of Invasive Cardiology 14(8): 439-442
Quirk, F.; Dickinson, C.; Baune, B.; Leicht, A.; Golledge, J. 2012: Pilot trial of motivational interviewing in patients with peripheral artery disease International Angiology: a Journal of the International Union of Angiology 31(5): 468-473
Li, J.; Liu, Z.; Zhang, S.; Shen, Z.; Fan, Z.; Zeng, Y.; Xie, H.; Wang, C.; Jin, X.; Fang, Q.; Zhu, W. 2015: Activated clotting time post therapeutic anticoagulation with unfractionated heparin in patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 43(5): 408-412
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246
Germing, A.; von Dryander, S.; Bojara, W.; Lawo, T.; Grewe, P.; Machraoui, A.; Lemke, B. 2002: Coronary artery stenting in diabetes mellitus--unfavourable clinical outcome due to increased rate of myocardial ischemia and percutaneous interventions European Journal of Medical Research 7(6): 265-270
Lanzi, S.; Ney, B.; Deslarzes-Dubuis, C.él.; Mazzolai, L.; Calanca, L. 2019: Exercise training therapy in patients with lower extremity peripheral artery disease Revue Medicale Suisse 15(674): 2252-2255
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Coughlin, P.A.; Gulati, V.; Mavor, A.I.D.; Gough, M.J.; Homer-Vanniasinkam, S. 2007: Risk factor awareness in patients with peripheral arterial disease Journal of Cardiovascular Surgery 48(6): 735-740
Cooperman, M.; Pflug, B.; Martin, E.W.; Evans, W.E. 1978: Cardiovascular risk factors in patients with peripheral vascular disease Surgery 84(4): 505-509
Griga, T.; Hebler, U.; Voigt, E.; Tromm, A.; May, B. 2000: Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease Hepato-Gastroenterology 47(36): 1604-1607